Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2
Peter van Doorn, Jan Rosing, Connie Duckers, et al.
Thrombosis and Haemostasis (2018) Vol. 118, Iss. 07, pp. 1194-1202
Open Access | Times Cited: 20

Showing 20 citing articles:

The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V
Juan A. De Pablo-Moreno, Luis Javier Serrano, Luis Revuelta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8283-8283
Open Access | Times Cited: 49
Cryo-EM structures of human coagulation factors V and Va
Eliza A. Ruben, Michael Rau, James A. J. Fitzpatrick, et al.
Blood (2021) Vol. 137, Iss. 22, pp. 3137-3144
Open Access | Times Cited: 40
Genetic factors, risk prediction and AI application of thrombotic diseases
Rong Wang, Liang Tang, Yu Hu
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Severe thrombophilia in a factor V‐deficient patient homozygous for the Ala2086Asp mutation (FV Besançon)
Elisabetta Castoldi, Nathalie Hézard, Guillaume Mourey, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 5, pp. 1186-1199
Open Access | Times Cited: 22
The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency
Juan A. De Pablo-Moreno, Andrea Miguel-Batuecas, María de Sancha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6243-6243
Open Access | Times Cited: 8
Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII
Yanyan Shao, Wenman Wu, Guan-qun Xu, et al.
Blood (2019) Vol. 134, Iss. 20, pp. 1745-1754
Open Access | Times Cited: 22
Impaired factor V–related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations
Naruto Shimonishi, Kenichi Ogiwara, Junko Yoshida, et al.
Blood Advances (2023) Vol. 7, Iss. 12, pp. 2831-2842
Open Access | Times Cited: 7
The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review
Shu He, Honglie Cao, Charlotte Thålin, et al.
Seminars in Thrombosis and Hemostasis (2020) Vol. 47, Iss. 01, pp. 063-073
Closed Access | Times Cited: 19
F5‐Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV‐short production
Karen L. Zimowski, Teodolinda Petrillo, Michelle Ho, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 7, pp. 1653-1665
Closed Access | Times Cited: 17
Factor V variants in bleeding and thrombosis
Adarsh K. Mohapatra, Alice M. Todaro, Elisabetta Castoldi
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 1, pp. 102330-102330
Open Access | Times Cited: 1
High Mutational Heterogeneity, and New Mutations in the Human Coagulation Factor V Gene. Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies
Sara Bernal, Irene Peláez, Laura Alías, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9705-9705
Open Access | Times Cited: 12
Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia
Paul E. R. Ellery, Ida Hilden, P. Thyregod, et al.
Haemophilia (2019) Vol. 25, Iss. 6, pp. 1083-1091
Open Access | Times Cited: 10
Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP
Adrienn Teráz-Orosz, Magdalena Gierula, Anastasis Petri, et al.
Blood Advances (2021) Vol. 6, Iss. 2, pp. 704-715
Open Access | Times Cited: 9
In vitro evaluation of factor IX as novel treatment for factor XI deficiency
Kamran Bakhtiari, Joost C.M. Meijers
Blood (2019) Vol. 134, Iss. 6, pp. 573-575
Open Access | Times Cited: 7
Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations
Luis Javier Serrano, Mariano García‐Arranz, Juan A. De Pablo-Moreno, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5802-5802
Open Access | Times Cited: 4
Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα
Peter van Doorn, Jan Rosing, Elena Campello, et al.
Thrombosis and Haemostasis (2019) Vol. 120, Iss. 01, pp. 055-064
Closed Access | Times Cited: 5
Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis
Mark P. Ward, Ezzeldin M. Ibrahim, Sharon O’Toole, et al.
Thrombosis Research (2024) Vol. 246, pp. 109251-109251
Open Access
F5‐Atlanta: Factor V‐short strikes again
Elisabetta Castoldi
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 7, pp. 1638-1640
Open Access | Times Cited: 2
Factor V mutation illuminates the dominant anticoagulant role and importance of an unidentified platelet modifier
Josefin Ahnström, Gary E. Gilbert
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 5, pp. 1168-1170
Open Access | Times Cited: 1
Prothrombotic variants as modifiers of clinical phenotype in four related individuals with haemophilia A
Laura Carrel, Sarah E. Arnold-Croop, Ty Achtermann, et al.
Haemophilia (2021) Vol. 27, Iss. 4
Closed Access
Page 1

Scroll to top